产品名称 | NebuSelect™ Recombinant Human CD93/C1q R1, hFc-tag |
---|---|
目录号 | NBL-242854 |
别名 | CD93/C1q R1; C1q/MBL/SPA receptor; C1qR; C1qR(p); C1qRp; CDw93; CD93; C1QR1; MXRA4; ECSM3; dJ737E23.1 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9NPY3 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242854-100ug | 100ug | Inquire | Inquire | |
NBL-242854-1mg | 1mg | Inquire | Inquire | |
NBL-242854-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD93/C1q R1, hFc-tag
Catalog#:
NBL-242854
Description:
NebuSelect™ Recombinant Human CD93/C1q R1, hFc-tag(Cat#NBL-242854) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Thr22-Lys580.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 85 kDa. Due to glycosylation, the protein migrates to 115-120 kDa based on Bis-Tris PAGE result.
Target Name:
CD93/C1q R1; C1q/MBL/SPA receptor; C1qR; C1qR(p); C1qRp; CDw93; CD93; C1QR1; MXRA4; ECSM3; dJ737E23.1
Target Information:
CD93 has been shown critical roles in inflammatory and immune diseases. CD93 silencing increased IL-6 and TSLP, but not IL-33 levels in culture supernatants. HDM-induced asthma mice showed significant airway hyperresponsiveness and inflammation with Th2 cytokine activation, along with decreased CD93 expression in bronchial epithelial cells and lung homogenates but increased serum CD93 levels.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.